Skip to main content
Fig. 3 | Journal of Ovarian Research

Fig. 3

From: MiR-29c-3p, a target miRNA of LINC01296, accelerates tumor malignancy: therapeutic potential of a LINC01296/miR-29c-3p axis in ovarian cancer

Fig. 3

The influence of LINC01296/ miR-29c-3p axis on the proliferation of OC cells. The SKOV3 and OVCAR3 cells were treated with miR-29c-3p inhibitor, si-LINC01296, or miR-29c-3p inhibitor plus si-LINC01296. CCK8 assay (a, d) and Colony formation assay (b-c, e-f) were performed to detect the proliferation of OC cells in different conditions. **P < 0.01 vs. control group, ##P < 0.01 vs. miR-29c-3p inhibitor group

Back to article page